Issue: Captoril 6.25 mg strength tablets have been discontinued from the single source vendor with no alternatives available.
Further information and practice implications.
Newsroom
Resolution: The heparin 10,000 units/mL X 0.5 mL vials and 1,000 units/mL X 10 mL vials are in consistent enough supply with current allocations to return to regular wardstock practices in NH.
Resolution: The oxytocin 10 units/mL x 1 mL single-use vials are in consistent enough supply with current allocations to return to regular wardstock practices at UHNBC.
The Issue: Ranitidine injectable is on backorder due to a Health Canada hold on distribution while further quality assurance testing is performed. This is related to the NDMA impurity found in oral ranitidine products earlier this year.
The Issue: Chloroquine 250 mg tablets will expire December 31, 2019 with no alternative supply expected from the single source vendor until 2022.
Anticipated Availability: Resupply date of March 2022.
The Issue: Numerous lots of lidocaine hydrochloride 2% topical jelly X 30 mL sterile tubes have been recalled from Aspen Pharma due to a potential for foreign particle in the tube.
Anticipated Availability: A new lot is expected in January 2020.
Resolution: The shortage of lidocaine 2% with EPINEPHrine 1:100,000 X 20 mL vial is now resolved.
Further information and practice implications.